LIPOSOMES - An Exclusive Market Insight Report Update

RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles.

Hyderabad, India (prHWY.com) July 2, 2012 - April 18, 2012 - RI Technologies' ( http://www.researchimpact.com ) market insight report on Liposomes gives an insight into global Liposomes market. The report provides market analytics by application, and by therapeutic area. The market is divided by Application into Therapeutic, Cosmetic and Other; and by Therapeutics into Antifungal, Anticancer, Ophthalmic and Other. The study also provides information regarding products and technologies in the field of Liposomes. Business profiles of 40 major companies are discussed in the report. The report covers more than 180 companies that are engaged in Liposomes research and supply of products and/or services. Compilation of Worldwide Patents and Research related to Liposomes is also provided. Projections and estimates are also illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World with 148 exclusive graphically represented exhibits. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, and other areas of concern is also co vered in the report.

Liposomes belong to the class of nanosized unilamellar phospholipid bilayer vesicles. These are considered as the most promising and comprehensively studied drug delivery vehicles. The applications of the Liposome-formulated drugs have multiplied over the years and they are now part of cancer treatment and systemic or local fungal infections. The unique features of Liposome-formulated drugs are that they remain biologically inert, biocompatible and restrict the cause of unwanted toxic or antigenic reactions. They maintain a high level of popularity in the field of drug research. The application of Liposomes have enormously undergone transformations owing to use in the treatment of solid tumors. The tumors are targeted with Liposomes containing bisphosphonate which reduces the tumor associated macrophages. The other important developments such as use of genetic components as therapeutic molecules have further enhanced the scope of Liposomes based therapy. The components of Liposomes present in the lipid-DNA complexes, commonly called lipoplexes, combat with the viral gene transfection systems.

The global liposomes' market is projected at a CAGR of 15%, through 2005-2015. The market for liposomes presents attractive growth opportunities, driven by growing demand for increasingly effective drugs in the field of pharmaceuticals, and niche applications in other emerging areas. Liposome drug delivery systems have been instrumental in the formulation of potent drugs to enhance therapeutics. A majority of liposome formulations are designed to bring down toxicity.

Presently pharmaceutical products of liposome-based therapeutics exhibit a better understanding of lipid-drug interactions as well as liposome disposition mechanisms. Among these mechanisms are included the impeding of the fast clearance of liposomes. This is achieved by exercising control over surface hydration, charge and size. Continued improvements of bio-membrane sensors and liposome delivery systems that are competent in the association of other membrane-bound proteins in vivo could allow selective delivery of therapeutic compounds to chosen intracellular target areas. As large quantities of stable and cost-effective liposomes are manufactured many new applications will surface.

About RI Technologies

RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

###

Tag Words: liposomes

Categories: Biotech

Press Release Contact
http://www.researchimpact.com/ MIR028_LIPOSOMES.aspx

Customer Support: contactus@researchimpact.com. Call us at INDIA: +91 9676994272 / UK: 076-24-057837

Link To This Press Release:

URL HTML Code